Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CR845 in hemodialysis patients with uremic pruritus
NCT02858726Phase 3Completed
- Sponsor
- Cara Therapeutics, Inc.
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of difelikefalin in uremic pruritus, sponsored by Cara Therapeutics, Inc.. Started Jun 2016; status: completed.
02
Drugs
difelikefalin
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT02858726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858726.